Dr. Steven D. Nathan, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 45
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 111
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
VA license 0101050649 -
Critical Care Medicine (Internal Medicine) Physician
VA license 0101050649 -
Internal Medicine Physician
VA license 0101050649
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Inova Fairfax Hospital Falls Church, VA
- Inova Alexandria Hospital Alexandria, VA
- Inova Loudoun Hospital Leesburg, VA
- Winchester Medical Center Winchester, VA
- Inova Mount Vernon Hospital Alexandria, VA
Medical groups
- Inova Health Care Services (1,817 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 111
- Services billed
- 215
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 135 | 86 |
| New patient office or other outpatient visit, 60-74 minutes | 27 | 27 |
| Established patient office or other outpatient visit, 30-39 minutes | 19 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ofev (nintedanib esylate) | 199 |
| Prednisone Other prescribers in Falls Church, VA | 64 |
| Pirfenidone | 45 |
| Tyvaso Dpi (treprostinil) | 37 |
| Opsumit (macitentan) | 35 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Falls Church, VA | 26 |
| Furosemide Other prescribers in Falls Church, VA | 21 |
| Mycophenolate Mofetil Other prescribers in Falls Church, VA | 20 |
| Fluticasone Propionate Other prescribers in Falls Church, VA | 18 |
| Tadalafil | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 248 payments worth $240,520 in total to this clinician.
| Boehringer Ingelheim Pharmaceuticals, Inc. | $113,280 |
|---|---|
| United Therapeutics Corporation | $104,656 |
| E.r. Squibb & Sons, L.l.c. | $10,706 |
| AbbVie Inc. | $5,849 |
| Boehringer Ingelheim International GmbH | $4,891 |
| Argenx US, Inc. | $338 |
| Bayer HealthCare Pharmaceuticals Inc. | $174 |
| Insmed, Inc. | $146 |
| Consulting Fee | $132,851 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $81,670 |
| Travel and Lodging | $20,219 |
| Food and Beverage | $5,780 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 16, 2025 | Consulting Fee | $13,370 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Consulting Fee | $11,700 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Consulting Fee | $11,460 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Consulting Fee | $10,505 |
| United Therapeutics Corporation Jan 31, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $8,200 |
| United Therapeutics Corporation Aug 8, 2025 | Consulting Fee REMODULIN · Pulmonary Arterial Hypertension | $8,200 |
| United Therapeutics Corporation Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $7,260 |
| United Therapeutics Corporation Jul 25, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $6,950 |
| United Therapeutics Corporation Oct 27, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $6,930 |
| United Therapeutics Corporation Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $6,600 |
All 122 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) | $6,340 |
| United Therapeutics Corporation Dec 30, 2025 | Travel and Lodging travel to Maywood, IL · in-kind | $504 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 19, 2025 | Consulting Fee | $3,900 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Consulting Fee | $11,700 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Travel and Lodging travel to Washington, DC · in-kind | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $6,340 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $6,340 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 11, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Roanoke, VA · in-kind | $1,268 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 8, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $6,340 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 8, 2025 | Compensation for services other than consulting (speaking, faculty) OFEV · RESPIRATORY | $2,440 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Springfield, MA · in-kind | $1,344 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Springfield, MA · in-kind | $332 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 3, 2025 | Consulting Fee | $5,850 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 19, 2025 | Travel and Lodging travel to Norfolk, VA · in-kind | $1,632 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 13, 2025 | Consulting Fee | $3,900 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 13, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind | $646 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 13, 2025 | Travel and Lodging travel to Philadelphia, PA · in-kind | $301 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 12, 2025 | Travel and Lodging travel to Rehoboth Beach, DE · in-kind | $1,199 |
| E.r. Squibb & Sons, L.l.c. Oct 30, 2025 | Consulting Fee | $1,375 |
| United Therapeutics Corporation Oct 27, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $6,930 |
| United Therapeutics Corporation Oct 27, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Chicago, IL | $329 |
| Boehringer Ingelheim International GmbH Oct 20, 2025 | Consulting Fee | $3,600 |
| Boehringer Ingelheim International GmbH Oct 20, 2025 | Travel and Lodging travel to Amsterdam, Netherlands · in-kind | $46.34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 16, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $330 |
| United Therapeutics Corporation Oct 10, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $1,890 |
| United Therapeutics Corporation Oct 8, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $580 |
| United Therapeutics Corporation Oct 6, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,640 |
| United Therapeutics Corporation Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,280 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,390 |
| United Therapeutics Corporation Sep 24, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $315 |
| United Therapeutics Corporation Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $3,960 |
| United Therapeutics Corporation Sep 4, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Greenville, NC | $1,294 |
| United Therapeutics Corporation Aug 28, 2025 | Travel and Lodging travel to Miami, FL | $205 |
| United Therapeutics Corporation Aug 28, 2025 | Travel and Lodging travel to Miami, FL | $63.00 |
| United Therapeutics Corporation Aug 28, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $53.50 |
| United Therapeutics Corporation Aug 20, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $198 |
| United Therapeutics Corporation Aug 15, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $230 |
| United Therapeutics Corporation Aug 15, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $40.31 |
| United Therapeutics Corporation Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $1,270 |
| United Therapeutics Corporation Aug 13, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $870 |
| United Therapeutics Corporation Aug 13, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $473 |
| United Therapeutics Corporation Aug 8, 2025 | Consulting Fee REMODULIN · Pulmonary Arterial Hypertension | $8,200 |
| United Therapeutics Corporation Aug 8, 2025 | Travel and Lodging REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX | $42.00 |
| United Therapeutics Corporation Aug 7, 2025 | Travel and Lodging REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX · in-kind | $377 |
| United Therapeutics Corporation Aug 7, 2025 | Travel and Lodging REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX · in-kind | $345 |
| United Therapeutics Corporation Aug 7, 2025 | Travel and Lodging REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX | $24.98 |
| United Therapeutics Corporation Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $5,280 |
| AbbVie Inc. Jul 30, 2025 | Consulting Fee | $488 |
| United Therapeutics Corporation Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $2,640 |
| United Therapeutics Corporation Jul 28, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX | $165 |
| United Therapeutics Corporation Jul 28, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX | $42.00 |
| United Therapeutics Corporation Jul 28, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX · in-kind | $10.00 |
| United Therapeutics Corporation Jul 28, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX | $10.00 |
| United Therapeutics Corporation Jul 25, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $6,950 |
| United Therapeutics Corporation Jul 24, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Detroit, MI · in-kind | $384 |
| United Therapeutics Corporation Jul 24, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Detroit, MI · in-kind | $298 |
| United Therapeutics Corporation Jul 24, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Detroit, MI | $42.00 |
| United Therapeutics Corporation Jul 18, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX · in-kind | $216 |
| United Therapeutics Corporation Jul 16, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $1,575 |
| United Therapeutics Corporation Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,270 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jul 7, 2025 | Consulting Fee | $5,730 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jul 7, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind | $444 |
| AbbVie Inc. Jul 3, 2025 | Consulting Fee | $2,275 |
| AbbVie Inc. Jun 25, 2025 | Consulting Fee | $2,438 |
| United Therapeutics Corporation Jun 24, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $103 |
| United Therapeutics Corporation Jun 24, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $40.31 |
| United Therapeutics Corporation Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $1,270 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 16, 2025 | Consulting Fee | $13,370 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 16, 2025 | Consulting Fee | $4,775 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 16, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind | $140 |
| United Therapeutics Corporation Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $1,270 |
| E.r. Squibb & Sons, L.l.c. Jun 9, 2025 | Consulting Fee | $1,194 |
| Boehringer Ingelheim International GmbH Jun 5, 2025 | Consulting Fee | $1,200 |
| E.r. Squibb & Sons, L.l.c. Jun 4, 2025 | Consulting Fee | $5,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 22, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 19, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind | $150 |
| United Therapeutics Corporation May 16, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $103 |
| United Therapeutics Corporation May 16, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $15.91 |
| United Therapeutics Corporation May 16, 2025 | Travel and Lodging travel to Fort Lauderdale, FL · in-kind | $15.91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 14, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind | $444 |
| E.r. Squibb & Sons, L.l.c. May 13, 2025 | Consulting Fee | $1,238 |
| Argenx US, Inc. Apr 30, 2025 | Consulting Fee | $338 |
| United Therapeutics Corporation Apr 18, 2025 | Travel and Lodging travel to Dallas, TX | $42.00 |
| United Therapeutics Corporation Apr 18, 2025 | Travel and Lodging travel to Dallas, TX | $14.00 |
| United Therapeutics Corporation Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $7,260 |
| United Therapeutics Corporation Apr 16, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Leominster, MA | $60.70 |
| United Therapeutics Corporation Apr 10, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Leominster, MA · in-kind | $219 |
| United Therapeutics Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,940 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Consulting Fee | $11,460 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Consulting Fee | $10,505 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 2, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 2, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 1, 2025 | Travel and Lodging travel to San Francisco, CA · in-kind | $517 |
| United Therapeutics Corporation Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $6,600 |
| United Therapeutics Corporation Mar 26, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $4,060 |
| United Therapeutics Corporation Mar 21, 2025 | Travel and Lodging travel to Denver, CO | $21.00 |
| United Therapeutics Corporation Mar 21, 2025 | Travel and Lodging travel to Denver, CO | $14.00 |
| United Therapeutics Corporation Mar 19, 2025 | Travel and Lodging travel to Jackson, TN · in-kind | $465 |
| United Therapeutics Corporation Mar 17, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX · in-kind | $399 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 17, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $146 |
| United Therapeutics Corporation Mar 5, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Greenville, NC | $15.94 |
| United Therapeutics Corporation Feb 28, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $304 |
| E.r. Squibb & Sons, L.l.c. Feb 26, 2025 | Consulting Fee | $1,380 |
| United Therapeutics Corporation Feb 25, 2025 | Travel and Lodging travel to Springfield, MA · in-kind | $345 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Feb 17, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $471 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Feb 17, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $322 |
| United Therapeutics Corporation Feb 14, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $313 |
| United Therapeutics Corporation Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,400 |
| United Therapeutics Corporation Feb 11, 2025 | Travel and Lodging travel to Chesterfield, MO | $36.98 |
| United Therapeutics Corporation Feb 7, 2025 | Travel and Lodging travel to Chesterfield, MO · in-kind | $209 |
| United Therapeutics Corporation Feb 3, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $642 |
| United Therapeutics Corporation Jan 31, 2025 | Consulting Fee TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $8,200 |
| United Therapeutics Corporation Jan 30, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Dallas, TX · in-kind | $369 |
| United Therapeutics Corporation Jan 30, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Dallas, TX · in-kind | $349 |
| United Therapeutics Corporation Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,400 |
| United Therapeutics Corporation Jan 27, 2025 | Travel and Lodging travel to Chesterfield, MO · in-kind | $312 |
| United Therapeutics Corporation Jan 27, 2025 | Travel and Lodging travel to Charleston, SC | $29.00 |
| United Therapeutics Corporation Jan 27, 2025 | Travel and Lodging travel to Charleston, SC | $25.20 |
| United Therapeutics Corporation Jan 17, 2025 | Travel and Lodging travel to Charleston, SC · in-kind | $178 |
| AbbVie Inc. Jan 15, 2025 | Consulting Fee | $575 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $427,790 in research payments for these studies, mostly to the institutions running them.
- Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
United Therapeutics Corporation · Completed · NCT05776225
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.